Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV/HIV coinfected patients: effect on cognitive function, fatigue, and mental health

[1]  H. Tillmann,et al.  Persistent neuropsychiatric impairment in HCV patients despite clearance of the virus?! , 2017, Journal of viral hepatitis.

[2]  E. Singer,et al.  Improvements in brain and behavior following eradication of hepatitis C , 2017, Journal of NeuroVirology.

[3]  H. Jessen,et al.  Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: A pilot study , 2017, Neurology.

[4]  F. Dabis,et al.  Short article: Fatigue in the long term after HCV treatment in HIV–HCV-coinfected patients functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort) , 2016, European journal of gastroenterology & hepatology.

[5]  J. Rockstroh,et al.  Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01). , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Boellaard,et al.  Cerebral microglia activation in hepatitis C virus infection correlates to cognitive dysfunction , 2016, Journal of viral hepatitis.

[7]  Todd M. Allen,et al.  Deep sequencing of hepatitis C virus reveals genetic compartmentalization in cerebrospinal fluid from cognitively impaired patients , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[8]  K. Reddy,et al.  Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection. , 2016, Gastroenterology.

[9]  Michael J. Taylor,et al.  CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease , 2015, Journal of NeuroVirology.

[10]  Claus Bundesen,et al.  Dissociable spatial and non-spatial attentional deficits after circumscribed thalamic stroke , 2015, Cortex.

[11]  D. Kriz,et al.  A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C. , 2015, Journal of psychosomatic research.

[12]  E. Singer,et al.  Neuroimaging abnormalities, neurocognitive function, and fatigue in patients with hepatitis C , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[13]  I. Grant,et al.  Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment , 2014, Journal of NeuroVirology.

[14]  P. Szewczyk,et al.  Value of Perfusion-Weighted MR Imaging in the Assessment of Early Cerebral Alterations in Neurologically Asymptomatic HIV-1-Positive and HCV-Positive Patients , 2014, PloS one.

[15]  M. Peeters,et al.  Validation of the Fatigue Severity Scale in chronic hepatitis C , 2014, Health and Quality of Life Outcomes.

[16]  Stefan Zeuzem,et al.  Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. , 2014, The New England journal of medicine.

[17]  M. Stepanova,et al.  Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C). , 2014, Journal of hepatology.

[18]  T. Habekost,et al.  Testing attention: Comparing the ANT with TVA-based assessment , 2014, Behavior research methods.

[19]  M. Scheurlen,et al.  Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C , 2013, Hepatology.

[20]  R. Lenkinski,et al.  Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. , 2012, Journal of hepatology.

[21]  G. Reynolds,et al.  Hepatitis C virus infects the endothelial cells of the blood-brain barrier. , 2012, Gastroenterology.

[22]  D. Brooks,et al.  Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation , 2012, Journal of viral hepatitis.

[23]  S. Newman,et al.  Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS , 2012, Journal of the Neurological Sciences.

[24]  Claus Bundesen,et al.  Generalizing parametric models by introducing trial-by-trial parameter variability: The case of TVA , 2011 .

[25]  M. McAndrews,et al.  Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[26]  Claus Bundesen,et al.  Prompt but inefficient: nicotine differentially modulates discrete components of attention , 2011, Psychopharmacology.

[27]  Peter Bublak,et al.  Staged decline of visual processing capacity in mild cognitive impairment and Alzheimer's disease , 2010, Alzheimer's & Dementia.

[28]  D. Allen,et al.  Trail-Making Test , 2010 .

[29]  J. Allsop,et al.  Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. , 2008, Journal of hepatology.

[30]  G. Pagnoni,et al.  Neuropsychological Performance in Persons With Chronic Fatigue Syndrome: Results From a Population-Based Study , 2008, Psychosomatic Medicine.

[31]  E. Singer,et al.  Neurocognition in Individuals Co-Infected with HIV and Hepatitis C , 2008, Journal of addictive diseases.

[32]  P. Maruff,et al.  Improved cognitive function as a consequence of hepatitis C virus treatment * , 2007, HIV medicine.

[33]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[34]  Kathrin Finke,et al.  Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease. , 2006, Brain : a journal of neurology.

[35]  J. Gorman,et al.  Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study , 2005, AIDS.

[36]  T. Guilarte,et al.  Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS , 2005, Journal of NeuroVirology.

[37]  M. Manns,et al.  Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. , 2004, Journal of hepatology.

[38]  B. Haslinger,et al.  Psychomotor Slowing in Hepatitis C and HIV Infection , 2004, Journal of acquired immune deficiency syndromes.

[39]  J. Rakela,et al.  Search for Hepatitis C Virus Negative-Strand RNA Sequences and Analysis of Viral Sequences in the Central Nervous System: Evidence of Replication , 2002, Journal of Virology.

[40]  J. Allsop,et al.  Evidence for a cerebral effect of the hepatitis C virus , 2001, The Lancet.

[41]  J. Ware,et al.  Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. , 1998, Journal of clinical epidemiology.

[42]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[43]  O. Selnes.  A Compendium of Neuropsychological Tests , 1991, Neurology.

[44]  C. Bundesen.  A theory of visual attention. , 1990, Psychological review.

[45]  S. Ishihara.  TESTS FOR COLOUR BLINDNESS , 1952 .

[46]  L. Gerber,et al.  Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus Infection. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  H. Tillmann.  Hepatitis C virus infection: when is a cure not a cure? , 2014, The Journal of infectious diseases.

[48]  Rolf Brickenkamp,et al.  Test d2 - Revision , 2010 .

[49]  Klaus W. Lange,et al.  Regensburger Wortflüssigkeits-Test (RWT) , 2004 .

[50]  Silke Lux,et al.  Verbaler Lern- und Merkfähigkeitstest , 2001 .

[51]  G. Bäumler,et al.  Farbe-Wort-Interferenztest (FWIT) nach J. R. Stroop , 1985 .

[52]  C. A. Boneau,et al.  The effects of violations of assumptions underlying the test. , 1960, Psychological bulletin.